Abstract
Pneumonia is the third leading cause of death in Brazil and in the world, and the first among infectious diseases. The use of clinical disease severity assessment scores to predict adverse outcomes has arguably improved patient care. However, although scores based on clinical and laboratory variables, such as the CURB-65 and the Pneumonia Severity Index, are accurate for defining the prog…